Pre-Market Trend | OrbusNeich (6929.HK): Golden Cross Rebuilds Momentum, Volume Remains the QuestionTechnical Forecast·Sep 1 at 01:22 AM06929-0.52%
OrbusNeich Medical Group declares interim dividend of HKD 0.08 per sharePUBT·Aug 14 at 04:04 AM06929-0.52%
OrbusNeich Medical Group schedules board meeting to review interim resultsPUBT·Jul 31 at 08:31 AM06929-0.52%
OrbusNeich Launches Pivotal Japan Trial for Coronary Drug-Coated BalloonTip Ranks·Jul 22 at 10:08 AM06929-0.52%
OrbusNeich targets end-2027 completion of Japan trial enrollment for proprietary drug-coated balloonPUBT·Jul 22 at 09:42 AM06929-0.52%
Pre-market trend | ORBUSNEICH (6929.HK) 5/11 Medical devices warming up, are low-level bullish signals emerging?Technical Forecast·May 12 at 01:00 AM06929-0.52%159102-0.36%
OrbusNeich Medical Group Holdings Limited (6929) Gets a Buy from CICCTip Ranks·Mar 16 at 05:25 AM06929-0.52%159883+0.23%
ORBUSNEICH's final dividend is expected to increase by 20% to 12 cents, planning to declare a regular interim dividendStheadline·Mar 13 at 07:18 AM06929-0.52%
ORBUSNEICH: Will actively consider distributing an interim dividendAASTOCKS·Mar 13 at 06:45 AM06929-0.52%
In the "Performance" report, ORBUSNEICH's annual net profit is USD 41.899 million, an increase of 5.5%, with a final dividend of HKD 0.12AASTOCKS·Mar 12 at 08:37 AM06929-0.52%516500-0.63%
ORBUSNEICH's research and production base in Hangzhou has topped outAASTOCKS·Oct 17, 2025 at 01:35 AM06929-0.52%
